← Latest papers
📄 medicine

Effects of Growth Hormone Therapy on Sleep-Disordered Breathing and Metabolic Parameters in Patients with Prader–Willi Syndrome According to Genetic Subtype

This study demonstrates that while one year of growth hormone therapy in children with Prader–Willi syndrome significantly improves linear growth without worsening metabolic parameters, it induces early increases in obstructive sleep-disordered breathing, particularly among patients with type II deletions, highlighting the importance of molecular subtype in predicting respiratory risks and the need for close polysomnographic monitoring.

Original authors: Onur Akın, ESRA YAZARLI, Nursel KARA ULU, Birce Sunman, Dicle Canoruç Emet, Emre ÖZER, Gönül Yardımcı, Mehmet KOÇER, Volkan TEKİN, Sevinç ODABAŞI GÜNEŞ, Deniz Torun, Sinan YETKİN

Published 2026-07-31
📖 6 min read🧠 Deep dive

Original authors: Onur Akın, ESRA YAZARLI, Nursel KARA ULU, Birce Sunman, Dicle Canoruç Emet, Emre ÖZER, Gönül Yardımcı, Mehmet KOÇER, Volkan TEKİN, Sevinç ODABAŞI GÜNEŞ, Deniz Torun, Sinan YETKİN

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Imagine the human body as a highly sophisticated, custom-built house. Inside this house, there's a master control room called the hypothalamus. This room manages everything from how hungry you feel to how you sleep and how your body grows. Now, imagine a rare glitch in the blueprints for this house, specifically in a section of the genetic code known as chromosome 15. This glitch causes Prader-Willi syndrome (PWS). In this condition, the control room doesn't get the right signals, leading to a house that struggles to grow tall, has trouble managing its weight, and often has a "leaky roof" when it comes to breathing while sleeping.

To help fix the "growing tall" part, doctors often install a special tool called recombinant human growth hormone (rhGH). Think of this like a powerful fertilizer for the body's growth spurt. It's known to make children with PWS grow taller and build more muscle. However, there's a nagging worry in the medical community: could this fertilizer accidentally clog the air vents? Some studies suggest that growth hormone might cause the tissues in the throat to swell up, like a sponge soaking up water, which could make it harder to breathe while sleeping. This is a big deal because breathing problems can be dangerous.

But here's the twist: not all houses with this blueprint glitch are built exactly the same way. The genetic error can happen in two main ways. Sometimes, a whole chunk of the blueprint is missing (called a deletion). Other times, the house has two copies of the blueprint from the mother and none from the father (called uniparental disomy). Even within the "missing chunk" group, the size of the missing piece can vary. Scientists have long wondered if these different blueprint errors mean the house reacts differently to the growth hormone fertilizer. Does the type of glitch change how the breathing pipes react?

The Study: Checking the Blueprint and the Pipes

A team of researchers at Gülhane Training and Research Hospital decided to investigate this very question. They looked back at the records of 66 children with Prader-Willi syndrome who had been treated with growth hormone for at least 12 months. They wanted to see three things: Did the kids grow taller? Did their blood sugar and fat levels stay healthy? And most importantly, did their breathing while sleeping get worse, and did this depend on their specific genetic blueprint?

The researchers split the kids into groups based on their genetic "blueprint": those with a deletion (45 kids) and those with maternal uniparental disomy (mUPD) (21 kids). The deletion group was further broken down into Type I (a larger missing piece) and Type II (a smaller missing piece). Before the treatment started, and again after 3 to 6 months, the kids underwent a polysomnography (PSG). You can think of this as a "sleep camera" that records every breath, heart beat, and brain wave to see if the airway is getting blocked.

The Findings: Growth is Good, But the Pipes Need Watching

The results were a mix of good news and a specific warning label.

First, the "fertilizer" worked exactly as hoped for growth. After one year, the children's height improved significantly. Their height standard deviation score (a way of measuring how tall they are compared to average kids) went up, but their weight and body mass index (BMI) didn't get worse. Their blood sugar and cholesterol levels also stayed stable. This suggests that, for the most part, the growth hormone is safe for the body's metabolism in the short term.

However, the "sleep camera" told a different story about the airways. For the group of children who started with normal breathing (fewer than 5 breathing pauses per hour), the breathing got slightly worse in the first 3 to 6 months of treatment. The number of times they stopped breathing (the Apnea-Hypopnea Index, or AHI) went up, mostly because the airway was getting blocked (obstructive apnea).

Here is where the blueprint matters. The researchers found that this breathing trouble wasn't the same for everyone.

  • The mUPD group: These children, who had two copies of the mother's blueprint, did not show a significant change in their breathing patterns during the first few months.
  • The Deletion group: These children, who were missing a piece of the blueprint, did show a significant increase in breathing pauses.

But the plot thickens even more when looking at the size of the missing piece.

  • Type I Deletion (Larger missing piece): These kids did not show a significant worsening of their breathing.
  • Type II Deletion (Smaller missing piece): These kids showed a significant and sharp increase in breathing pauses. Their total breathing pauses jumped from a median of 2.00 events per hour at the start to 7.15 events per hour after 3–6 months. Their obstructive breathing (the kind caused by a blocked throat) went from 0.18 to 2.15 events per hour.

What This Means

The study suggests that the specific genetic blueprint a child with Prader-Willi syndrome has might act like a switch for how their throat reacts to growth hormone. It appears that children with the Type II deletion are the most sensitive; their airways seem to swell up more easily when they start the treatment, leading to more breathing trouble early on.

The authors are careful to say this is a suggestion based on their data, not a final, unchangeable law of nature. They note that their study was a look back at records, and they had to exclude some kids who needed immediate surgery or breathing machines, which might have changed the numbers slightly. However, the pattern is clear enough to sound an alarm.

The main takeaway is that while growth hormone helps kids with Prader-Willi syndrome grow taller without messing up their blood sugar, doctors need to be extra vigilant about checking their breathing. Specifically, if a child has the Type II deletion, they should be watched very closely during the first six months of treatment. It's like knowing that a specific type of house needs a more frequent check-up on its ventilation system when a new heating system is installed. By knowing the genetic blueprint ahead of time, doctors can catch breathing problems early and keep the house safe while the child grows.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →